Esperion Therapeutics ESPR Goodwill and intangible assets, net
Goodwill and intangible assets, net at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's goodwill and intangible assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's goodwill and intangible assets, net?
- Esperion Therapeutics (ESPR) reported goodwill and intangible assets, net of $56K in Q1 2026.
- How has Esperion Therapeutics's goodwill and intangible assets, net changed year-over-year?
- Esperion Therapeutics's goodwill and intangible assets, net decreased by 0.0% year-over-year, from $56K to $56K.
- What is the long-term trend for Esperion Therapeutics's goodwill and intangible assets, net?
- Over 5 years (2020 to 2025), Esperion Therapeutics's goodwill and intangible assets, net has grown at a 0.0% compound annual growth rate (CAGR), from $56K to $56K.